COMMUNIQUÉS West-GlobeNewswire

Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
29/09/2026
All measurable sequencing metrics show profound improvement over Platinum Pro BRANFORD, Conn., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a [...]
Evosep and Mass Dynamics Join Forces to Standardize Proteomics Sample Preparation for Pharma
29/09/2026
SINGAPORE, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Evosep™, a global leader in standardized proteomics workflows, today announced a strategic collaboration with Mass Dynamics™, the collaborative software environment for [...]
NewGen Announces Pricing of $1.25 Million Public Offering
29/09/2026
BANGKOK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative [...]
Rancho Bernardo Dentistry Releases Patient Guide Comparing Professional Teeth Whitening and At-Home Kits
28/09/2026
Rancho Bernardo dentist Dr. James Spalenka says, “The biggest whitening mistake patients make is choosing convenience over supervision, and it's costing them results” San Diego, CA 92128, Sept. 28, 2026 (GLOBE NEWSWIRE [...]
Olivaro Drops Publishes 2026 Supplement Facts and Serving Information for Its Liquid Dietary Supplement
28/09/2026
Chromium Picolinate, Maca, Gymnema, and a 200 mg Proprietary Blend: Olivaro's Full Ingredient List and Serving Directions Explained Lakeland, FL, Sept. 28, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency
28/09/2026
First and only FDA-approved treatment of peripheral thyrotoxicosis in adults and pediatric patients with monocarboxylate transporter 8 (MCT8) deficiency in the United States Egetis launches Egetis RareLink™, the [...]
Currus Biologics announces FDA IND clearance for Phase 1 trial of CUR-001 in mesothelin-positive advanced refractory solid tumours
29/09/2026
The first clinical programme from Currus’ BEAT platform, designed to overcome the barriers that have limited CAR T-cell therapy in solid tumours CUR-001 combines CURB-001, Currus’ BEAT bispecific antibody, with CURT-001 [...]
Mint Ops becomes an official reseller of the Coro cybersecurity platform, bringing single-platform security to Canadian dental practices
29/09/2026
The dental business services company secured its own infrastructure with Coro before offering it to clients - and is publishing its pricing, per user, on day one. Winnipeg, MANITOBA, Sept. 28, 2026 (GLOBE NEWSWIRE) -- [...]
HUTCHMED Announces Submission of US NDA for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer
29/09/2026
— Filing seeks approval for a biomarker-directed, all-oral treatment option for patients whose tumors have MET overexpression or amplification, after progression on an EGFR-TKI therapy — — Application supported by [...]
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
29/09/2026
SAN DIEGO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio ® ” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
ProText Mobility Issues Significant Inter-Quarter Shareholder Update: ABSA Confirms Inaugural Digital-Asset Custody Pilot as TXTM Advances Global RWA and Uplist Strategy
28/09/2026
Company highlights a significant institutional milestone, advancing its intended regulated-exchange uplist through institutional custody, deployed SVLT infrastructure, proprietary nanotechnology, international real- [...]
Interra Health Named Quarterfinalist in the 2026 Digital Health & AI Awards
28/09/2026
BOSTON, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Interra Health , which delivers the first patient-centric medication prescribing experience, announced today that it has been named a Quarterfinalist in the 2026 Digital Health [...]
Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)
28/09/2026
DEGEVMA™ is now FDA-approved across all indications of the reference product, Xgeva ® (denosumab), to help prevent bone complications in adults with advanced cancer that has spread to the bone, for the treatment of [...]
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
28/09/2026
FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density bone SANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing [...]
MedLegalPsych Launches Independent Psychiatric Assessment and IME Services in Winnipeg for Insurers, Employers, and Disability Case Managers
28/09/2026
Led by Canadian-trained psychiatrist Dr. Armita Saligheh, MD, FRCPC, the new Manitoba practice provides psychiatric independent medical examinations, file-review opinions, and medico-legal reports that go beyond [...]
Nyxoah Nomme Liam Kelly au Poste de Chief Executive Officer
28/09/2026
INFORMATIONS RÉGLEMENTÉES INFORMATIONS PRIVILÉGIÉES Nyxoah Nomme Liam Kelly au Poste de Chief Executive Officer La Société renforce sa présence et son orientation stratégiques aux États-Unis Mont-Saint-Guibert, Belgique [...]
Nyxoah Appoints Liam Kelly as Chief Executive Officer
28/09/2026
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Appoints Liam Kelly as Chief Executive Officer Further strengthening the Company’s strategic U.S. presence and focus Mont-Saint-Guibert, Belgium – September 28, 2026, 10: [...]
Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
28/09/2026
CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced [...]
Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results
28/09/2026
Conference Call Scheduled for Today, September 28, 2026, at 5:00 p.m. ET LITTLETON, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of [...]

Pages